Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazumasa Tsukamoto is active.

Publication


Featured researches published by Kazumasa Tsukamoto.


Journal of the American College of Cardiology | 2008

Prediction of Cardiac Death in Hemodialysis Patients by Myocardial Fatty Acid Imaging

Masato Nishimura; Kazumasa Tsukamoto; Naoyuki Hasebe; Nagara Tamaki; Kenjiro Kikuchi; Toshihiko Ono

OBJECTIVES The aim was to evaluate the potential of single-photon emission computed tomography (SPECT) to predict cardiac death in chronic hemodialysis patients using the iodinated fatty acid analogue iodine-123 123I-beta-methyl iodophenyl-pentadecanoic acid (BMIPP). BACKGROUND We previously reported that BMIPP SPECT could detect asymptomatic coronary artery disease with high sensitivity in hemodialysis patients. METHODS We prospectively enrolled 375 asymptomatic hemodialysis patients who had undergone dual SPECT using 123I-BMIPP and 201thallium (Tl) chloride. Patients who had a clinical history of myocardial infarction and/or coronary revascularization were excluded from the study. Uptake on SPECT images was graded in 17 segments on a 5-point scale (0 normal, 4 absent) and assessed as summed BMIPP or Tl scores. RESULTS During a 3.6 +/- 1.0-year follow-up, 57 patients who had undergone coronary revascularization within 60 days of SPECT were excluded from the analysis. Among the remaining 318 patients (male/female: 170/148; 64 +/- 12 years of age), 50 died of cardiac events (acute myocardial infarction 22, congestive heart failure 17, cardiac sudden death 11). Stepwise Cox hazard analysis associated cardiac death with age (> or =70 years) and with severely abnormal BMIPP SPECT images (BMIPP summed scores > or =12: hazard ratio 21.894; p < 0.0001). Kaplan-Meier analysis showed that the cardiac death-free survival rates at 3 years were 61% and 98% in patients with BMIPP summed scores of > or =12 and <12, respectively. CONCLUSIONS Severely impaired myocardial fatty acid metabolism, which might mainly reflect repetitive myocardial ischemia, can identify a high-risk group of cardiac death among hemodialysis patients.


International Journal of Cardiology | 2012

Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia

Masao Moroi; Akira Yamashina; Kazumasa Tsukamoto; Tsunehiko Nishimura

BACKGROUND As an initial management strategy for stable ischemic heart disease (IHD), coronary revascularization therapy is thought to be equal to optimal medical therapy alone regarding prognosis. METHODS Whether or not the effects of revascularization on the prognosis of patients with stable IHD are associated with the amount of ischemic myocardium detected by nuclear stress imaging was evaluated. This retrospective study analyzed data from 4629 patients with suspected or known IHD who underwent gated stress myocardial-perfusion SPECT at 117 hospitals in Japan. The follow-up periods were three years and the combined endpoints consisted of cardiac death, nonfatal myocardial infarction, and congestive heart failure requiring hospitalization. After matching propensity scores between patients who underwent early revascularization and those who did not (n=316 per group), we compared cardiac event rates in relation to the amount of ischemic myocardium. RESULTS Cardiac event rates did not significantly differ between patients who underwent early revascularization and those who did not (5.4% vs. 6.4%). Among patients with ≤ 5%, 6-10%, and >10% ischemic myocardium, cardiac event rates were 8%, 3% and 0% respectively, who underwent early revascularization compared with 4.5%, 6.1%, and 12.3%, respectively, among those who did not. Cardiac event rates were significantly lower among patients with >10% ischemic myocardium who underwent early revascularization compared with those who did not (0% vs. 12.3%, p=0.0062). CONCLUSIONS Coronary revascularization for stable IHD does not decrease major cardiac events in all patients but might do in patients with moderate to severe ischemia.


Kidney International | 2011

Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease

Masato Nishimura; Kazumasa Tsukamoto; Nagara Tamaki; Kenjiro Kikuchi; Noriyuki Iwamoto; Toshihiko Ono

The incidence of cardiac death is higher among patients receiving dialysis compared with the general population. Although obstructive coronary artery disease is involved in cardiac deaths in the general population, deaths in hemodialysis patients occur in the apparent absence of obstructive coronary artery disease. To study this further, we prospectively enrolled 155 patients receiving hemodialysis after angiography had confirmed the absence of obstructive coronary lesions. All patients were examined by single-photon emission computed tomography using the iodinated fatty acid analog, BMIPP, the uptake of which was graded in 17 standard myocardial segments and assessed as summed scores. Insulin resistance was determined using the homeostasis model assessment index of insulin resistance (HOMA-IR). During a mean follow-up of 5.1 years, 42 patients died of cardiac events. Stepwise Cox hazard analysis associated cardiac death with reduced BMIPP uptake and increased insulin resistance. Patients were assigned to subgroups based on BMIPP summed scores and HOMA-IR cutoff values for cardiac death of 12 and 5.1, respectively, determined by receiver operating characteristic analysis. Cardiac death-free survival rates at 5 years were the lowest (32.2%) in the subgroup with both a summed score and assessment equal to or above the cutoff values compared with any other combination (52.9-98.7%) above, equal to, or below the thresholds. Thus, impaired myocardial fatty acid metabolism and insulin resistance may be associated with cardiac death among hemodialysis patients without obstructive coronary artery disease.


Environmental Health and Preventive Medicine | 2001

Chronic effect of training on neutrophil functions in humans

Kazumasa Tsukamoto; Katsuhiko Suzuki; Kazuhiko Machida

We performed this study to evaluate the chronic effect of training on neutrophil functions in humans. Twenty-six university students (14 males and 12 females) with a mean age of 19.1±0.8 years were divided into the athlete group and the control group based on answers given to a written questionnaire. The capacity of circulating neutrophils to ingest bacteria (phagocytosis) and to produce superoxide (nitroblue tetrazolium reduction) was measured under resting conditions in the absence of training activities. In addition, we measured hematological and serum biochemical parameters.The present analyses revealed that the frequency of subjective symptoms concerning susceptibility to infections (sum of males and females) was higher in the athlete group than in the control group (p<0.05). In the investigation of males, hemoglobin and serum protein levels of the athlete group were lower than that of the control group (p<0.01, p<0.05, respectively). Although total and differential leukocyte counts, and phagocytic activity of neutrophils were not significantly different between the groups, superoxide productivity of neutrophils in the male athlete group was higher than that in the control group (p<0.05).Since significant differences were observed in hemoglobin and serum protein levels in the male athletes, the training is considered to have been intense. An increase was noted in the neutrophil superoxide production along with these changes, but no significant difference was observed in the phagocytic activity. Therefore, there is the possibility of superoxide overproduction, which may lead to tissue damage.


Circulation | 2012

Cardiac Event Risk in Japanese Subjects Estimated Using Gated Myocardial Perfusion Imaging, in Conjunction With Diabetes Mellitus and Chronic Kidney Disease

Kenichi Nakajima; Shinro Matsuo; Chio Okuyama; Tsuguru Hatta; Kazumasa Tsukamoto; Shigeyuki Nishimura; Akira Yamashina; Hideo Kusuoka; Tsunehiko Nishimura


Circulation | 2011

Validation of Automated Quantitation of Myocardial Perfusion and Fatty Acid Metabolism Abnormalities on SPECT Images

Keiichiro Yoshinaga; Takayuki Matsuki; Akiyoshi Hashimoto; Kazumasa Tsukamoto; Tomoaki Nakata; Nagara Tamaki


Circulation | 2011

Estimation of cardiac event risk by gated myocardial perfusion imaging and quantitative scoring methods based on a multi-center J-ACCESS database

Kenichi Nakajima; Shinro Matsuo; Koichi Okuda; Hiroshi Wakabayashi; Kazumasa Tsukamoto; Tsunehiko Nishimura


Journal of Clinical Laboratory Analysis | 2002

Relationships between lifestyle factors and neutrophil functions in the elderly

Kazumasa Tsukamoto; Katsuhiko Suzuki; Kazuhiko Machida; Chinatsu Saiki; Rumiko Murayama; Minoru Sugita


International Journal of Cardiovascular Imaging | 2013

Prognostic value of automated SPECT scoring system for coronary artery disease in stress myocardial perfusion and fatty acid metabolism imaging

Tomoaki Nakata; Akiyoshi Hashimoto; Takayuki Matsuki; Keiichiro Yoshinaga; Kazumasa Tsukamoto; Nagara Tamaki


Circulation | 2012

Detection of Coronary Artery Disease Using Automated Quantitation of Myocardial Perfusion on Single-Photon Emission Computed Tomography Images From Patients With Angina Pectoris Without Prior Myocardial Infarction

Mamoru Nanasato; Sumio Morita; Ruka Yoshida; Takanaga Niimi; Mitsuo Sugimoto; Kazumasa Tsukamoto; Haruo Hirayama; Toyoaki Murohara

Collaboration


Dive into the Kazumasa Tsukamoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenjiro Kikuchi

Asahikawa Medical College

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge